Sculptra is an FDA-approved injectable medical therapy designed to address age-related collagen loss and manage the clinical presentation of facial lines and volume deficits. It is increasingly utilised by medical professionals for these indications.
This treatment employs poly-L-lactic acid (PLLA), a biocompatible and biodegradable synthetic material, to stimulate endogenous collagen production. This process aims to progressively restore facial volume and improve skin structure. Sculptra is intended to provide results that are consistent with natural facial anatomy and can be considered as a non-surgical option for managing certain age-related structural changes.